Clinic
Planned Parenthood Mar Monte, INC.
Planned Parenthood Mar Monte, INC. was paid $2.64M by Medicaid between Mar 2021 and Dec 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 14% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD MAR MONTE, INC.
MOUNTAIN VIEW, CA 94040
MOUNTAIN VIEW, CA 94040
33aNPI1386299899assigned 08/02/2019
33bProvider typeCommunity Health Clinic/Center
28Total paid$2.64M
24GClaims54,809
24DCodes billed47
24AFirst – last monthMar 2021 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#135 of 288
Median peer was paid$2.15M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 6,771 | $310K | |
| 2022 | 7,842 | $371K | |
| 2023 | 20,496 | $1.11M | |
| 2024incomplete | 19,700 | $849K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 5,175 | 4,908 | $363K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 11% | 381 | 375 | $298K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 3,199 | 3,114 | $278K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 9.9% | 1,943 | 1,934 | $262K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.2% | 3,772 | 3,643 | $244K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.6% | 1,015 | 1,014 | $201K |
| S4993 | Contraceptive pills for birth control | 5.5% | 1,439 | 1,425 | $146K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.5% | 643 | 640 | $146K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 3.9% | 291 | 290 | $104K |
| J3490 | Unclassified drugs | 3.3% | 2,838 | 2,534 | $88K |
| 87806 | 3.3% | 4,240 | 3,950 | $87K | |
| 90651 | 2.8% | 347 | 347 | $73K |
35 more codes
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.5% | 2,552 | $67K |
| 11981 | 2.4% | 366 | $63K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.0% | 1,451 | $53K |
| 58300 | 1.2% | 388 | $32K | |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 17 | $18K |
| 11976 | <1% | 286 | $18K | |
| S5000 | Prescription drug, generic | <1% | 1,945 | $16K |
| 81025 | <1% | 5,546 | $13K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 270 | $10K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 15 | $10K |
| 99000 | <1% | 3,334 | $9K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 2,971 | $9K |
| A4267 | Contraceptive supply, condom, male, each | <1% | 830 | $7K |
| 83986 | <1% | 3,190 | $7K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 502 | $6K |
| 58301 | <1% | 221 | $6K | |
| 99401 | <1% | 163 | $3K | |
| 81002 | <1% | 1,131 | $2K | |
| 99070 | <1% | 518 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 245 | $790.49 |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 299 | $626.23 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 68 | $535.57 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $426.81 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 936 | $153.90 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 936 | $153.37 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $129.52 |
| 85018 | <1% | 60 | $77.03 | |
| 90686 | <1% | 19 | $9.92 | |
| 90656 | 0% | 29 | $0.00 | |
| 3079F | 0% | 180 | $0.00 | |
| 3074F | 0% | 487 | $0.00 | |
| 3075F | 0% | 31 | $0.00 | |
| Q3014 | Telehealth originating site facility fee | 0% | 23 | $0.00 |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 0% | 23 | $0.00 |
| 3078F | 0% | 454 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOTSIFF, TOM (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.